Market Research Report - 217039
Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Antibodies
|Published by||BioSeeker Group AB|
|Published||Content info||6794 Pages|
|Triple Analysis: Prostate Cancer, Protein Kinase Inhibitors and Antibodies|
|Published: November 1, 2012||Content info: 6794 Pages||
This triple analysis focuses on cancer drug development strategies in one specific cancer indication (Prostate Cancer), one mechanism/target/effect area (Protein Kinase Inhibitors) and one compound specific area (Antibodies). Each of these three individual parts is evaluated according to standardized criteria in a five pillar pipeline drug assessment methodology to compare drug development strategies in oncology. This makes it easy to find and compare analysis not only within one single cancer focus area but also between different areas.